A Phase 2 Randomized Vehicle-Controlled Double-Blind Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 weeks to Subjects with Papulopustular Rosacea
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
To evaluate the safety and efficacy of once daily application of three doses of omiganan topical gel compared to vehicle topical gel in subjects with papulopustular rosacea
Description
To evaluate the safety and efficacy of once daily application of three doses of omiganan topical gel compared to vehicle topical gel in subjects with papulopustular rosacea
Details
| Condition | Papulopustular Rosacea |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX3590 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.